ANTI-MYOSIN VIIA

ANTI-MYOSIN VIIA Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  Monoclonal Anti-Myosin VI antibody produced in mouse has been used in:
  
  • enzyme-linked immunosorbent assay (ELISA)
  • immunoprecipitation
  • western blot assay
  • immunohistochemistry
  
  

• Allgemeine Beschreibung

  Monoclonal Anti-Myosin VI (mouse IgG1 isotype) is derived from the MUD-19 hybridoma produced by the fusion of mouse myeloma cells and splenocytes from mice immunized with a synthetic peptide corresponding to amino acids of human myosin VI. Myosin VI is a relatively abundant widespread unconventional myosin composed of an N-terminal motor domain, a light chain binding neck region, a coil-coiled region and a highly conserved C-terminal domain.

• Biochem/physiol Actions

  Myosin VI is involved in the generation of cell shape change, cell motility, membrane remodeling and possibly in organelle and particle transport or tethering. It is also involved in membrane trafficking pathways in cultured mammalian cells where it is associated with the membrane ruffles and the trans-Golgi network. Myosin VI plays an essential role in the development of the mouse inner ear where it is expressed in the hair cell body, in the actin-rich cuticular plate at the base of the stereocilia and in the peri cuticular necklace region. Myosin VI gene mutations are involved in deafness and balance defects in the Snell′s Waltzer mouse. Myosin VI is present in the Golgi complex and may regulate vesicular transport across the membranes.

ANTI-MYOSIN VIIA Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(4)Suppliers